Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pancreatitis

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 145 articles:
HTML format



Single Articles


    May 2021
  1. KOSCHNY R, Lang M, Hackert T
    Enormously dilated pancreatic duct.
    Gut. 2021 May 7. pii: gutjnl-2021-324335. doi: 10.1136/gutjnl-2021-324335.
    PubMed    


  2. GENIN E, Cooper DN, Masson E, Ferec C, et al
    NGS mismapping confounds the clinical interpretation of the PRSS1 p.Ala16Val (c.47C>T) variant in chronic pancreatitis.
    Gut. 2021 May 7. pii: gutjnl-2021-324943. doi: 10.1136/gutjnl-2021-324943.
    PubMed    


    April 2021
  3. CHANDRA V, McAllister F
    Therapeutic potential of microbial modulation in pancreatic cancer.
    Gut. 2021 Apr 27. pii: gutjnl-2019-319807. doi: 10.1136/gutjnl-2019-319807.
    PubMed    


  4. HACKENG WM, Brosens LAA, Kim JY, O'Sullivan R, et al
    Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size.
    Gut. 2021 Apr 13. pii: gutjnl-2020-322595. doi: 10.1136/gutjnl-2020-322595.
    PubMed     Abstract available


  5. KLOESCH B, Ionasz V, Paliwal S, Hruschka N, et al
    A GATA6-centred gene regulatory network involving HNFs and DeltaNp63 controls plasticity and immune escape in pancreatic cancer.
    Gut. 2021 Apr 12. pii: gutjnl-2020-321397. doi: 10.1136/gutjnl-2020-321397.
    PubMed     Abstract available


  6. XIE Z, Gao Y, Ho C, Li L, et al
    Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment.
    Gut. 2021 Apr 7. pii: gutjnl-2020-323014. doi: 10.1136/gutjnl-2020-323014.
    PubMed     Abstract available


  7. OVERBEEK KA, Levink IJM, Koopmann BDM, Harinck F, et al
    Long-term yield of pancreatic cancer surveillance in high-risk individuals.
    Gut. 2021 Apr 5. pii: gutjnl-2020-323611. doi: 10.1136/gutjnl-2020-323611.
    PubMed     Abstract available


    March 2021
  8. GLEESON FC, Jeraldo P, Levy MJ, Murphy SJ, et al
    Composition, diversity and potential utility of intervention-naive pancreatic cancer intratumoral microbiome signature profiling via endoscopic ultrasound.
    Gut. 2021 Mar 22. pii: gutjnl-2021-324031. doi: 10.1136/gutjnl-2021-324031.
    PubMed    


  9. ZHOU T, Liu J, Xie Y, Yuan S, et al
    ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4.
    Gut. 2021 Mar 5. pii: gutjnl-2020-321952. doi: 10.1136/gutjnl-2020-321952.
    PubMed     Abstract available


  10. KOLODKIN-GAL D, Roitman L, Ovadya Y, Azazmeh N, et al
    Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions.
    Gut. 2021 Mar 1. pii: gutjnl-2020-321112. doi: 10.1136/gutjnl-2020-321112.
    PubMed     Abstract available


    February 2021
  11. TACELLI M, Zaccari P, Capurso G, Arcidiacono PG, et al
    Artificial intelligence in EUS for autoimmune pancreatitis: bias and real life.
    Gut. 2021 Feb 22. pii: gutjnl-2021-324338. doi: 10.1136/gutjnl-2021-324338.
    PubMed    


  12. SUN X, He X, Zhang Y, Hosaka K, et al
    Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism.
    Gut. 2021 Feb 10. pii: gutjnl-2020-322744. doi: 10.1136/gutjnl-2020-322744.
    PubMed     Abstract available


  13. PANDANABOYANA S, Moir J, Leeds JS, Oppong K, et al
    SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study.
    Gut. 2021 Feb 5. pii: gutjnl-2020-323364. doi: 10.1136/gutjnl-2020-323364.
    PubMed     Abstract available


  14. ADAM MG, Beyer G, Christiansen N, Kamlage B, et al
    Identification and validation of a multivariable prediction model based on blood plasma and serum metabolomics for the distinction of chronic pancreatitis subjects from non-pancreas disease control subjects.
    Gut. 2021 Feb 4. pii: gutjnl-2020-320723. doi: 10.1136/gutjnl-2020-320723.
    PubMed     Abstract available


    January 2021
  15. LUCHINI C, Grant RC, Scarpa A, Gallinger S, et al
    Microsatellite instability/mismatch repair deficiency in pancreatic cancers: the same or different?
    Gut. 2021 Jan 19. pii: gutjnl-2020-323805. doi: 10.1136/gutjnl-2020-323805.
    PubMed    


    November 2020
  16. RANA SS, Gupta R
    Walled of necrosis, disconnected pancreatic duct and metal stents: the debate continues!
    Gut. 2020 Nov 9. pii: gutjnl-2020-323190. doi: 10.1136/gutjnl-2020-323190.
    PubMed    


  17. FROST F, Kacprowski T, Ruhlemann M, Pietzner M, et al
    Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function.
    Gut. 2020 Nov 9. pii: gutjnl-2020-322753. doi: 10.1136/gutjnl-2020-322753.
    PubMed     Abstract available


  18. KEMPENEERS MA, Issa Y, Verdonk RC, Bruno M, et al
    Pain patterns in chronic pancreatitis: a nationwide longitudinal cohort study.
    Gut. 2020 Nov 6. pii: gutjnl-2020-322117. doi: 10.1136/gutjnl-2020-322117.
    PubMed     Abstract available


    October 2020
  19. SANO M, Takahashi R, Ijichi H, Ishigaki K, et al
    Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism.
    Gut. 2020 Oct 21. pii: gutjnl-2020-320608. doi: 10.1136/gutjnl-2020-320608.
    PubMed     Abstract available


  20. MARYA NB, Powers PD, Chari ST, Gleeson FC, et al
    Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis.
    Gut. 2020 Oct 7. pii: gutjnl-2020-322821. doi: 10.1136/gutjnl-2020-322821.
    PubMed     Abstract available



  21. Correction: Loss of Setd2 promotes Kras-induced acinar-to-ductal metaplasia and epithelia-mesenchymal transition during pancreatic carcinogenesis.
    Gut. 2020;69:e6.
    PubMed    


  22. DIAFERIA GR, Natoli G
    Transcription factors as drivers of distinct pancreatic ductal adenocarcinoma (PDAC) programmes: a role for HNF4A.
    Gut. 2020 Oct 1. pii: gutjnl-2020-322814. doi: 10.1136/gutjnl-2020-322814.
    PubMed    


    September 2020
  23. WEISS FU, Laemmerhirt F, Lerch MM
    Next generation sequencing pitfalls in diagnosing trypsinogen (PRSS1) mutations in chronic pancreatitis.
    Gut. 2020 Sep 28. pii: gutjnl-2020-322864. doi: 10.1136/gutjnl-2020-322864.
    PubMed    


  24. BARRETO SG, Habtezion A, Gukovskaya A, Lugea A, et al
    Critical thresholds: key to unlocking the door to the prevention and specific treatments for acute pancreatitis.
    Gut. 2020 Sep 24. pii: gutjnl-2020-322163. doi: 10.1136/gutjnl-2020-322163.
    PubMed     Abstract available


  25. GRANT RC, Denroche R, Jang GH, Nowak KM, et al
    Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma.
    Gut. 2020 Sep 15. pii: gutjnl-2020-320730. doi: 10.1136/gutjnl-2020-320730.
    PubMed     Abstract available


  26. YOUNG K, Lawlor RT, Ragulan C, Patil Y, et al
    Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours.
    Gut. 2020 Sep 3. pii: gutjnl-2020-321016. doi: 10.1136/gutjnl-2020-321016.
    PubMed     Abstract available


  27. GOUT J, Perkhofer L, Morawe M, Arnold F, et al
    Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer.
    Gut. 2020 Sep 1. pii: gutjnl-2019-319970. doi: 10.1136/gutjnl-2019-319970.
    PubMed     Abstract available


  28. VAN DEN BERG FF, van Dalen D, Hyoju SK, van Santvoort HC, et al
    Western-type diet influences mortality from necrotising pancreatitis and demonstrates a central role for butyrate.
    Gut. 2020 Sep 1. pii: gutjnl-2019-320430. doi: 10.1136/gutjnl-2019-320430.
    PubMed     Abstract available


    August 2020
  29. PERKHOFER L, Gout J, Roger E, Kude de Almeida F, et al
    DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives.
    Gut. 2020 Aug 27. pii: gutjnl-2019-319984. doi: 10.1136/gutjnl-2019-319984.
    PubMed     Abstract available


  30. CAMOLOTTO SA, Belova VK, Torre-Healy L, Vahrenkamp JM, et al
    Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4alpha and SIX1/4.
    Gut. 2020 Aug 21. pii: gutjnl-2020-321316. doi: 10.1136/gutjnl-2020-321316.
    PubMed     Abstract available


  31. BASHA J, Lakhtakia S, Nabi Z, Pal P, et al
    Impact of disconnected pancreatic duct on recurrence of fluid collections and new-onset diabetes: do we finally have an answer?
    Gut. 2020 Aug 18. pii: gutjnl-2020-321773. doi: 10.1136/gutjnl-2020-321773.
    PubMed    


  32. MASI AC, Oppong YEA, Haugk B, Lamb CA, et al
    Endoscopic ultrasound (EUS)-guided fine needle biopsy (FNB) formalin fixed paraffin-embedded (FFPE) pancreatic tissue samples are a potential resource for microbiota analysis.
    Gut. 2020 Aug 18. pii: gutjnl-2020-322457. doi: 10.1136/gutjnl-2020-322457.
    PubMed    


  33. HUANG J, Chen P, Liu K, Liu J, et al
    CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer.
    Gut. 2020 Aug 14. pii: gutjnl-2019-320441. doi: 10.1136/gutjnl-2019-320441.
    PubMed     Abstract available



  34. Correction: STING signalling protects against chronic pancreatitis by modulating Th17 response.
    Gut. 2020;69:e5.
    PubMed    


    July 2020
  35. AGHDASSI A, Tran QT, Bulla T, Bulow R, et al
    Focal pancreatic lesions in autoimmune pancreatitis and weight loss.
    Gut. 2020 Jul 22. pii: gutjnl-2020-321987. doi: 10.1136/gutjnl-2020-321987.
    PubMed    


    June 2020
  36. LESINSKI GB
    Braking the cell's cycle and invigorating T-cell immunity against pancreatic cancer.
    Gut. 2020 Jun 22. pii: gutjnl-2020-321497. doi: 10.1136/gutjnl-2020-321497.
    PubMed    


  37. GUBATAN J, Levitte S, Patel A, Balabanis T, et al
    Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California.
    Gut. 2020 Jun 3. pii: gutjnl-2020-321772. doi: 10.1136/gutjnl-2020-321772.
    PubMed    



  38. Correction: Management of patients with increased risk for familial pancreatic cancer: updated recommendations for the international cancer of the pancreas screening (CAPS) Consortium.
    Gut. 2020;69:e3.
    PubMed    


    May 2020
  39. KNUDSEN ES, Kumarasamy V, Chung S, Ruiz A, et al
    Targeting dual signalling pathways in concert with immune checkpoints for the treatment of pancreatic cancer.
    Gut. 2020 May 18. pii: gutjnl-2020-321000. doi: 10.1136/gutjnl-2020-321000.
    PubMed     Abstract available


  40. MOLINA-MONTES E, Coscia C, Gomez-Rubio P, Fernandez A, et al
    Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses.
    Gut. 2020 May 14. pii: gutjnl-2019-319990. doi: 10.1136/gutjnl-2019-319990.
    PubMed     Abstract available


  41. TAKAHASHI R, Macchini M, Sunagawa M, Jiang Z, et al
    Interleukin-1beta-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression.
    Gut. 2020 May 10. pii: gutjnl-2019-319912. doi: 10.1136/gutjnl-2019-319912.
    PubMed     Abstract available


    April 2020
  42. LUCHINI C, Brosens LAA, Wood LD, Chatterjee D, et al
    Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications.
    Gut. 2020 Apr 29. pii: gutjnl-2020-320726. doi: 10.1136/gutjnl-2020-320726.
    PubMed     Abstract available


  43. TIAN J, Zhu Y, Rao M, Cai Y, et al
    N(6)-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression.
    Gut. 2020 Apr 20. pii: gutjnl-2019-320179. doi: 10.1136/gutjnl-2019-320179.
    PubMed     Abstract available


  44. DE-MADARIA E, Sanchez-Marin C, Carrillo I, Vege SS, et al
    Design and validation of a patient-reported outcome measure scale in acute pancreatitis: the PAN-PROMISE study.
    Gut. 2020 Apr 3. pii: gutjnl-2020-320729. doi: 10.1136/gutjnl-2020-320729.
    PubMed     Abstract available


  45. HU Q, Wu J, Ren Y, Wu X, et al
    Degree of STING activation is associated with disease outcomes.
    Gut. 2020;69:792-794.
    PubMed    


    February 2020
  46. BANG JY, Hawes RH, Varadarajulu S
    Lumen-apposing metal stent placement for drainage of pancreatic fluid collections: predictors of adverse events.
    Gut. 2020 Feb 17. pii: gutjnl-2019-320539. doi: 10.1136/gutjnl-2019-320539.
    PubMed    


  47. STOLZENBERG-SOLOMON R, Derkach A, Moore S, Weinstein SJ, et al
    Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study.
    Gut. 2020 Feb 14. pii: gutjnl-2019-319811. doi: 10.1136/gutjnl-2019-319811.
    PubMed     Abstract available


    January 2020
  48. BIEDERSTADT A, Hassan Z, Schneeweis C, Schick M, et al
    SUMO pathway inhibition targets an aggressive pancreatic cancer subtype.
    Gut. 2020 Jan 30. pii: gutjnl-2018-317856. doi: 10.1136/gutjnl-2018-317856.
    PubMed     Abstract available


  49. WAN J, Haddock A, Edenfield B, Ji B, et al
    Transgenic expression of human PRSS2 exacerbates pancreatitis in mice.
    Gut. 2020 Jan 23. pii: gutjnl-2019-320399. doi: 10.1136/gutjnl-2019-320399.
    PubMed    


    December 2019
  50. FRAMPTON AE, Giovannetti E
    Diagnosing pancreatic ductal adenocarcinoma using plasma extracellular vesicle RNA profiles.
    Gut. 2019 Dec 4. pii: gutjnl-2019-319896. doi: 10.1136/gutjnl-2019-319896.
    PubMed    


    October 2019
  51. GOGGINS M, Overbeek KA, Brand R, Syngal S, et al
    Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
    Gut. 2019 Oct 31. pii: gutjnl-2019-319352. doi: 10.1136/gutjnl-2019-319352.
    PubMed     Abstract available


  52. LIANG C, Shi S, Qin Y, Meng Q, et al
    Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer.
    Gut. 2019 Oct 14. pii: gutjnl-2018-317163. doi: 10.1136/gutjnl-2018-317163.
    PubMed     Abstract available


  53. TOLOSA EJ, Fernandez-Zapico ME
    Targeting tumour microenvironment, a FAKtual challenge in pancreatic cancer.
    Gut. 2019 Oct 3. pii: gutjnl-2019-318962. doi: 10.1136/gutjnl-2019-318962.
    PubMed    


    September 2019
  54. YU S, Li Y, Liao Z, Wang Z, et al
    Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma.
    Gut. 2019 Sep 27. pii: gutjnl-2019-318860. doi: 10.1136/gutjnl-2019-318860.
    PubMed     Abstract available


  55. HEGYI E, Toth AZ, Vincze A, Szentesi A, et al
    Alcohol-dependent effect of PRSS1-PRSS2 haplotype in chronic pancreatitis.
    Gut. 2019 Sep 10. pii: gutjnl-2019-319729. doi: 10.1136/gutjnl-2019-319729.
    PubMed    


    August 2019
  56. HONG X, Qiao S, Li F, Wang W, et al
    Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system.
    Gut. 2019 Aug 28. pii: gutjnl-2018-317233. doi: 10.1136/gutjnl-2018-317233.
    PubMed     Abstract available


    July 2019
  57. NIU N, Lu P, Yang Y, He R, et al
    Loss of Setd2 promotes Kras-induced acinar-to-ductal metaplasia and epithelia-mesenchymal transition during pancreatic carcinogenesis.
    Gut. 2019 Jul 11. pii: gutjnl-2019-318362. doi: 10.1136/gutjnl-2019-318362.
    PubMed     Abstract available


  58. BANG JY, Navaneethan U, Hasan MK, Sutton B, et al
    Non-superiority of lumen-apposing metal stents over plastic stents for drainage of walled-off necrosis in a randomised trial.
    Gut. 2019;68:1200-1209.
    PubMed     Abstract available


    June 2019
  59. N KALIMUTHU S, Wilson GW, Grant RC, Seto M, et al
    Morphological classification of pancreatic ductal adenocarcinoma that predicts molecular subtypes and correlates with clinical outcome.
    Gut. 2019 Jun 14. pii: gutjnl-2019-318217. doi: 10.1136/gutjnl-2019-318217.
    PubMed     Abstract available


  60. COLLET L, Ghurburrun E, Meyers N, Assi M, et al
    Kras and Lkb1 mutations synergistically induce intraductal papillary mucinous neoplasm derived from pancreatic duct cells.
    Gut. 2019 Jun 1. pii: gutjnl-2018-318059. doi: 10.1136/gutjnl-2018-318059.
    PubMed     Abstract available


    May 2019
  61. SUN C, Liu M, An W, Mao X, et al
    Heterozygous Spink1 c.194+2T>C mutant mice spontaneously develop chronic pancreatitis.
    Gut. 2019 May 29. pii: gutjnl-2019-318790. doi: 10.1136/gutjnl-2019-318790.
    PubMed    


  62. DREWES AM, Kempeneers MA, Andersen DK, Arendt-Nielsen L, et al
    Controversies on the endoscopic and surgical management of pain in patients with chronic pancreatitis: pros and cons!
    Gut. 2019 May 25. pii: gutjnl-2019-318742. doi: 10.1136/gutjnl-2019-318742.
    PubMed    


  63. JIANG H, Liu X, Knolhoff BL, Hegde S, et al
    Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion.
    Gut. 2019 May 10. pii: gutjnl-2018-317424. doi: 10.1136/gutjnl-2018-317424.
    PubMed     Abstract available


    April 2019
  64. NEMETH BC, Orekhova A, Zhang W, Nortman SA, et al
    Novel p.K374E variant of CPA1 causes misfolding-induced hereditary pancreatitis with autosomal dominant inheritance.
    Gut. 2019 Apr 20. pii: gutjnl-2019-318751. doi: 10.1136/gutjnl-2019-318751.
    PubMed    


  65. BENITZ S, Straub T, Mahajan UM, Mutter J, et al
    Ring1b-dependent epigenetic remodelling is an essential prerequisite for pancreatic carcinogenesis.
    Gut. 2019 Apr 6. pii: gutjnl-2018-317208. doi: 10.1136/gutjnl-2018-317208.
    PubMed     Abstract available



  66. Correction: Mechanism of mitochondrial permeability transition pore induction and damage in the pancreas: inhibition prevents acute pancreatitis by protecting production of ATP.
    Gut. 2019 Apr 3. pii: gutjnl-2014-308553.
    PubMed    


    March 2019
  67. HESSMANN E, Ellenrieder V
    Chromatin remodelling controls pancreatic tissue fate.
    Gut. 2019 Mar 19. pii: gutjnl-2018-317486. doi: 10.1136/gutjnl-2018-317486.
    PubMed    


  68. GAISER RA, Halimi A, Alkharaan H, Lu L, et al
    Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer.
    Gut. 2019 Mar 14. pii: gutjnl-2018-317458. doi: 10.1136/gutjnl-2018-317458.
    PubMed     Abstract available


  69. LIN JH, Boulling A, Masson E, Cooper DN, et al
    Most unambiguous loss-of-function CPA1 mutations are unlikely to predispose to chronic pancreatitis.
    Gut. 2019 Mar 12. pii: gutjnl-2019-318564. doi: 10.1136/gutjnl-2019-318564.
    PubMed    


  70. JIANG SH, Zhu LL, Zhang M, Li RK, et al
    GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca(2+) signalling in a GABA-independent manner.
    Gut. 2019 Mar 2. pii: gutjnl-2018-317479. doi: 10.1136/gutjnl-2018-317479.
    PubMed     Abstract available



  71. Correction: Comprehensive characterisation ofcompartment-specific long non-coding RNAs associated with pancreatic ductaladenocarcinoma.
    Gut. 2019 Mar 2. pii: gutjnl-2017-314353.
    PubMed    


    February 2019
  72. SINGH S, Hasselluhn MC, Neesse A
    A tangled tale of molecular subtypes in pancreatic cancer.
    Gut. 2019 Feb 27. pii: gutjnl-2018-318086. doi: 10.1136/gutjnl-2018-318086.
    PubMed    


  73. KATO Y, Azuma K, Someda H, Shiokawa M, et al
    Case of IgG4-associated sclerosing cholangitis with normal serum IgG4 concentration, diagnosed by anti-laminin 511-E8 antibody: a novel autoantibody in patients with autoimmune pancreatitis.
    Gut. 2019 Feb 13. pii: gutjnl-2018-317934. doi: 10.1136/gutjnl-2018-317934.
    PubMed    


  74. SHI N, Liu T, de la Iglesia-Garcia D, Deng L, et al
    Duration of organ failure impacts mortality in acute pancreatitis.
    Gut. 2019 Feb 11. pii: gutjnl-2019-318241. doi: 10.1136/gutjnl-2019-318241.
    PubMed    


    January 2019
  75. ZHAO Q, Manohar M, Wei Y, Pandol SJ, et al
    STING signalling protects against chronic pancreatitis by modulating Th17 response.
    Gut. 2019 Jan 31. pii: gutjnl-2018-317098. doi: 10.1136/gutjnl-2018-317098.
    PubMed     Abstract available


  76. MAURER HC, Holmstrom SR, He J, Laise P, et al
    Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes.
    Gut. 2019 Jan 18. pii: gutjnl-2018-317706. doi: 10.1136/gutjnl-2018-317706.
    PubMed     Abstract available


    December 2018
  77. BAUER CA
    Immunosuppressive betaig-h3 links tumour stroma and dysfunctional T cells in pancreatic cancer.
    Gut. 2018 Dec 7. pii: gutjnl-2018-317735. doi: 10.1136/gutjnl-2018-317735.
    PubMed    


    November 2018
  78. BANG JY, Varadarajulu S
    Authors reply: treatment strategy for necrotising pancreatitis.
    Gut. 2018 Nov 17. pii: gutjnl-2018-317848. doi: 10.1136/gutjnl-2018-317848.
    PubMed    


  79. GOEHRIG D, Nigri J, Samain R, Wu Z, et al
    Stromal protein betaig-h3 reprogrammes tumour microenvironment in pancreatic cancer.
    Gut. 2018 Nov 10. pii: gutjnl-2018-317570. doi: 10.1136/gutjnl-2018-317570.
    PubMed     Abstract available


  80. CONWAY JR, Herrmann D, Evans TJ, Morton JP, et al
    Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine.
    Gut. 2018 Nov 5. pii: gutjnl-2018-316822. doi: 10.1136/gutjnl-2018-316822.
    PubMed     Abstract available


    October 2018
  81. LUNA J, Boni J, Cuatrecasas M, Bofill-De Ros X, et al
    DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth.
    Gut. 2018 Oct 20. pii: gutjnl-2018-316128. doi: 10.1136/gutjnl-2018-316128.
    PubMed     Abstract available


  82. KOUTSIOUMPA M, Hatziapostolou M, Polytarchou C, Tolosa EJ, et al
    Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming.
    Gut. 2018 Oct 18. pii: gutjnl-2017-315690. doi: 10.1136/gutjnl-2017-315690.
    PubMed     Abstract available


  83. WANG SC, Nassour I, Xiao S, Zhang S, et al
    SWI/SNF component ARID1A restrains pancreatic neoplasia formation.
    Gut. 2018 Oct 12. pii: gutjnl-2017-315490. doi: 10.1136/gutjnl-2017-315490.
    PubMed     Abstract available


  84. PUPPA G, Christinat Y, McKee TA
    Towards optimal pancreatic cyst fluid management: the need for standardisation.
    Gut. 2018 Oct 9. pii: gutjnl-2018-317156. doi: 10.1136/gutjnl-2018-317156.
    PubMed    


    September 2018
  85. NEESSE A, Bauer CA, Ohlund D, Lauth M, et al
    Stromal biology and therapy in pancreatic cancer: ready for clinical translation?
    Gut. 2018 Sep 3. pii: gutjnl-2018-316451. doi: 10.1136/gutjnl-2018-316451.
    PubMed     Abstract available


    August 2018
  86. RAJ D, Yang MH, Rodgers D, Hampton EN, et al
    Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma.
    Gut. 2018 Aug 18. pii: gutjnl-2018-316595. doi: 10.1136/gutjnl-2018-316595.
    PubMed     Abstract available


  87. ROSENDAHL J
    Unfolding the mystery of digestive enzyme misfolding in chronic pancreatitis.
    Gut. 2018 Aug 3. pii: gutjnl-2018-316985. doi: 10.1136/gutjnl-2018-316985.
    PubMed    


    July 2018
  88. HEGYI E, Sahin-Toth M
    Human CPA1 mutation causes digestive enzyme misfolding and chronic pancreatitis in mice.
    Gut. 2018 Jul 25. pii: gutjnl-2018-315994. doi: 10.1136/gutjnl-2018-315994.
    PubMed     Abstract available


    June 2018
  89. SCHEPERS NJ, Bakker OJ, Besselink MG, Ahmed Ali U, et al
    Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis.
    Gut. 2018 Jun 27. pii: gutjnl-2017-314657. doi: 10.1136/gutjnl-2017-314657.
    PubMed     Abstract available


    May 2018
  90. IKUTA K, Fukuda A, Ogawa S, Masuo K, et al
    Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice.
    Gut. 2018 May 24. pii: gutjnl-2017-315425. doi: 10.1136/gutjnl-2017-315425.
    PubMed     Abstract available



  91. Correction: Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Gut. 2018;67:994.
    PubMed    


    April 2018
  92. KONG F, Li L, Wang G, Deng X, et al
    VDR signaling inhibits cancer-associated-fibroblasts' release of exosomal miR-10a-5p and limits their supportive effects on pancreatic cancer cells.
    Gut. 2018 Apr 25. pii: gutjnl-2018-316627. doi: 10.1136/gutjnl-2018-316627.
    PubMed    


  93. ZEISSIG S, Sulk S, Brueckner S, Matthes K, et al
    Severe bleeding is a rare event in patients receiving lumen-apposing metal stents for the drainage of pancreatic fluid collections.
    Gut. 2018 Apr 20. pii: gutjnl-2018-316581. doi: 10.1136/gutjnl-2018-316581.
    PubMed    


  94. ENEA A, Pizzol A, Pinon M, Cisaro F, et al
    Hereditary pancreatitis in Paediatrics: the causative role of p.Leu104Pro mutation of cationic trypsinogen gene also in young subjects.
    Gut. 2018 Apr 17. pii: gutjnl-2018-316443. doi: 10.1136/gutjnl-2018-316443.
    PubMed    


  95. SCARPA A, Real FX, Luchini C
    Genetic unrelatedness of co-occurring pancreatic adenocarcinomas and IPMNs challenges current views of clinical management.
    Gut. 2018 Apr 16. pii: gutjnl-2018-316151. doi: 10.1136/gutjnl-2018-316151.
    PubMed    


  96. HUBERS LM, Vos H, Schuurman AR, Erken R, et al
    Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease.
    Gut. 2018;67:728-735.
    PubMed     Abstract available


    March 2018

  97. European evidence-based guidelines on pancreatic cystic neoplasms.
    Gut. 2018 Mar 24. pii: gutjnl-2018-316027. doi: 10.1136/gutjnl-2018-316027.
    PubMed     Abstract available


  98. YANG N, Li B, Pan Y, Tu J, et al
    Hypertriglyceridaemia delays pancreatic regeneration after acute pancreatitis in mice and patients.
    Gut. 2018 Mar 16. pii: gutjnl-2017-315560. doi: 10.1136/gutjnl-2017-315560.
    PubMed    


    February 2018
  99. ARNES L, Liu Z, Wang J, Maurer HC, et al
    Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma.
    Gut. 2018 Feb 10. pii: gutjnl-2017-314353. doi: 10.1136/gutjnl-2017-314353.
    PubMed     Abstract available


    January 2018
  100. LEE AYL, Dubois CL, Sarai K, Zarei S, et al
    Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma.
    Gut. 2018 Jan 23. pii: gutjnl-2017-314426. doi: 10.1136/gutjnl-2017-314426.
    PubMed     Abstract available


    December 2017
  101. MICHL P, Krug S
    Overcoming immune evasion in pancreatic cancer: the combination matters.
    Gut. 2017 Dec 7. pii: gutjnl-2017-315443. doi: 10.1136/gutjnl-2017-315443.
    PubMed    


  102. NYWENING TM, Belt BA, Cullinan DR, Panni RZ, et al
    Targeting both tumour-associated CXCR2(+) neutrophils and CCR2(+) macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma.
    Gut. 2017 Dec 1. pii: gutjnl-2017-313738. doi: 10.1136/gutjnl-2017-313738.
    PubMed     Abstract available


  103. WU H, Boulling A, Cooper DN, Li ZS, et al
    In vitro and in silico evidence against a significant effect of the SPINK1 c.194G>A variant on pre-mRNA splicing.
    Gut. 2017;66:2195-2196.
    PubMed    


    November 2017
  104. HUANG L, Jansen L, Balavarca Y, Molina-Montes E, et al
    Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations.
    Gut. 2017 Nov 20. pii: gutjnl-2017-314828. doi: 10.1136/gutjnl-2017-314828.
    PubMed     Abstract available


    October 2017
  105. CHOU A, Froio D, Nagrial AM, Parkin A, et al
    Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer.
    Gut. 2017 Oct 28. pii: gutjnl-2017-315144. doi: 10.1136/gutjnl-2017-315144.
    PubMed     Abstract available


  106. NOTTA F, Hahn SA, Real FX
    A genetic roadmap of pancreatic cancer: still evolving.
    Gut. 2017 Oct 9. pii: gutjnl-2016-313317. doi: 10.1136/gutjnl-2016-313317.
    PubMed     Abstract available


  107. BANG JY, Hebert-Magee S, Navaneethan U, Hasan MK, et al
    EUS-guided fine needle biopsy of pancreatic masses can yield true histology: results of a randomised trial.
    Gut. 2017 Oct 7. pii: gutjnl-2017-315154. doi: 10.1136/gutjnl-2017-315154.
    PubMed    


    September 2017
  108. SINGHI AD, McGrath K, Brand RE, Khalid A, et al
    Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
    Gut. 2017 Sep 28. pii: gutjnl-2016-313586. doi: 10.1136/gutjnl-2016-313586.
    PubMed     Abstract available


  109. TANG XY, Zou WB, Masson E, Hu LH, et al
    The CTRB1-CTRB2 risk allele for chronic pancreatitis discovered in European populations does not contribute to disease risk variation in the Chinese population due to near allele fixation.
    Gut. 2017 Sep 26. pii: gutjnl-2017-315180. doi: 10.1136/gutjnl-2017-315180.
    PubMed    


  110. HOPPER AD, Campbell JA
    Improving future studies in chronic pancreatitis: a paradigm shift in our understanding?
    Gut. 2017 Sep 22. pii: gutjnl-2017-315067. doi: 10.1136/gutjnl-2017-315067.
    PubMed    


  111. KROMREY ML, Bulow R, Hubner J, Paperlein C, et al
    Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study.
    Gut. 2017 Sep 6. pii: gutjnl-2016-313127. doi: 10.1136/gutjnl-2016-313127.
    PubMed     Abstract available


    August 2017
  112. VAN DIJK SM, Hallensleben NDL, van Santvoort HC, Fockens P, et al
    Acute pancreatitis: recent advances through randomised trials.
    Gut. 2017 Aug 24. pii: gutjnl-2016-313595. doi: 10.1136/gutjnl-2016-313595.
    PubMed     Abstract available


  113. IORIO V, Rosati A, D'Auria R, De Marco M, et al
    Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8+ T cell number and tumour growth in pancreatic cancer.
    Gut. 2017 Aug 11. pii: gutjnl-2017-314225. doi: 10.1136/gutjnl-2017-314225.
    PubMed    


  114. SARR MG
    Minimal access necrosectomy: the newest advance of many in the treatment of necrotising pancreatitis.
    Gut. 2017 Aug 10. pii: gutjnl-2017-314660. doi: 10.1136/gutjnl-2017-314660.
    PubMed    


  115. SELEZNIK GM, Reding T, Peter L, Gupta A, et al
    Development of autoimmune pancreatitis is independent of CDKN1A/p21-mediated pancreatic inflammation.
    Gut. 2017 Aug 3. pii: gutjnl-2016-313458. doi: 10.1136/gutjnl-2016-313458.
    PubMed     Abstract available


  116. VAN BRUNSCHOT S, Hollemans RA, Bakker OJ, Besselink MG, et al
    Minimally invasive and endoscopic versus open necrosectomy for necrotising pancreatitis: a pooled analysis of individual data for 1980 patients.
    Gut. 2017 Aug 3. pii: gutjnl-2016-313341. doi: 10.1136/gutjnl-2016-313341.
    PubMed     Abstract available


  117. SINGH VP
    High on drugs: lessons from opiates in pancreatitis.
    Gut. 2017 Aug 1. pii: gutjnl-2017-314506. doi: 10.1136/gutjnl-2017-314506.
    PubMed    


    July 2017
  118. ROSENDAHL J, Kirsten H, Hegyi E, Kovacs P, et al
    Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis.
    Gut. 2017 Jul 28. pii: gutjnl-2017-314454. doi: 10.1136/gutjnl-2017-314454.
    PubMed     Abstract available


    June 2017
  119. SCARPA A, Mafficini A
    Non-coding regulatory variations: the dark matter of pancreatic cancer genomics.
    Gut. 2017 Jun 28. pii: gutjnl-2017-314310. doi: 10.1136/gutjnl-2017-314310.
    PubMed    


  120. BARLASS U, Dutta R, Cheema H, George J, et al
    Morphine worsens the severity and prevents pancreatic regeneration in mouse models of acute pancreatitis.
    Gut. 2017 Jun 22. pii: gutjnl-2017-313717. doi: 10.1136/gutjnl-2017-313717.
    PubMed     Abstract available


  121. ZHANG M, Lykke-Andersen S, Zhu B, Xiao W, et al
    Characterising cis-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues.
    Gut. 2017 Jun 20. pii: gutjnl-2016-313146. doi: 10.1136/gutjnl-2016-313146.
    PubMed     Abstract available


  122. GOYAL J, Barkin JA, Barkin JS
    Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis.
    Gut. 2017 Jun 10. pii: gutjnl-2017-314460. doi: 10.1136/gutjnl-2017-314460.
    PubMed    


  123. MASSON E, Chen JM, Cooper DN, Ferec C, et al
    PRSS1 copy number variants and promoter polymorphisms in pancreatitis: common pathogenetic mechanism, different genetic effects.
    Gut. 2017 Jun 10. pii: gutjnl-2017-314443. doi: 10.1136/gutjnl-2017-314443.
    PubMed    


    May 2017
  124. COSTELLO E
    A metabolomics-based biomarker signature discriminates pancreatic cancer from chronic pancreatitis.
    Gut. 2017 May 24. pii: gutjnl-2016-313665. doi: 10.1136/gutjnl-2016-313665.
    PubMed    


    March 2017
  125. ZHU H, Lin H, Jin Z, Du Y, et al
    Re-evaluation of the role of lumen-apposing metal stents (LAMS) for pancreatic fl uid collection drainage.
    Gut. 2017 Mar 17. pii: gutjnl-2017-313949. doi: 10.1136/gutjnl-2017-313949.
    PubMed    


  126. KUJKO AA, Berki DM, Oracz G, Wejnarska K, et al
    A novel p.Ser282Pro CPA1 variant is associated with autosomal dominant hereditary pancreatitis.
    Gut. 2017 Mar 3. pii: gutjnl-2017-313816. doi: 10.1136/gutjnl-2017-313816.
    PubMed    


    February 2017
  127. SANCHEZ-AREVALO LOBO VJ, Fernandez LC, Carrillo-de-Santa-Pau E, Richart L, et al
    c-Myc downregulation is required for preacinar to acinar maturation and pancreatic homeostasis.
    Gut. 2017 Feb 3. pii: gutjnl-2016-312306. doi: 10.1136/gutjnl-2016-312306.
    PubMed     Abstract available


    January 2017
  128. WINDSOR JA
    Pancreatic enzyme replacement therapy in chronic pancreatitis: a long way to go.
    Gut. 2017 Jan 27. pii: gutjnl-2016-313455. doi: 10.1136/gutjnl-2016-313455.
    PubMed    


  129. WILLIAMS E, Beckingham I, El Sayed G, Gurusamy K, et al
    Updated guideline on the management of common bile duct stones (CBDS).
    Gut. 2017 Jan 25. pii: gutjnl-2016-312317. doi: 10.1136/gutjnl-2016-312317.
    PubMed     Abstract available


  130. MAYERLE J, Kalthoff H, Reszka R, Kamlage B, et al
    Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Gut. 2017 Jan 20. pii: gutjnl-2016-312432. doi: 10.1136/gutjnl-2016-312432.
    PubMed     Abstract available


  131. STECHER SS, Simon P, Friesecke S, Glitsch A, et al
    Delayed severe bleeding complications after treatment of pancreatic fluid collections with lumen-apposing metal stents.
    Gut. 2017 Jan 12. pii: gutjnl-2016-313562. doi: 10.1136/gutjnl-2016-313562.
    PubMed    


  132. KNUDSEN ES, Balaji U, Mannakee B, Vail P, et al
    Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility.
    Gut. 2017 Jan 10. pii: gutjnl-2016-313133. doi: 10.1136/gutjnl-2016-313133.
    PubMed     Abstract available


    December 2016
  133. NEMETH BC, Patai AV, Sahin-Toth M, Hegyi P, et al
    Misfolding cationic trypsinogen variant p.L104P causes hereditary pancreatitis.
    Gut. 2016 Dec 23. pii: gutjnl-2016-313451. doi: 10.1136/gutjnl-2016-313451.
    PubMed    


  134. RYAN BM, Venkatachalapathy SV, Huggett MT
    Safety of lumen-apposing metal stents (LAMS) for pancreatic fluid collection drainage.
    Gut. 2016 Dec 16. pii: gutjnl-2016-313388. doi: 10.1136/gutjnl-2016-313388.
    PubMed    


  135. DE LA IGLESIA-GARCIA D, Huang W, Szatmary P, Baston-Rey I, et al
    Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis.
    Gut. 2016 Dec 9. pii: gutjnl-2016-312529. doi: 10.1136/gutjnl-2016-312529.
    PubMed     Abstract available


  136. DUELL EJ
    Telomere length and pancreatic cancer risk: breaking down the evidence.
    Gut. 2016 Dec 5. pii: gutjnl-2016-313156. doi: 10.1136/gutjnl-2016-313156.
    PubMed    


    November 2016
  137. TEICH N, Bokemeyer B, Mohl W, Walldorf J, et al
    Blood group B is associated with azathioprine-induced acute pancreatitis in patients with IBD.
    Gut. 2016 Nov 14. pii: gutjnl-2016-313138. doi: 10.1136/gutjnl-2016-313138.
    PubMed    


  138. LEEDS JS, Nayar MK, Charnley RM, Oppong KW, et al
    Lumen-apposing metal stents for pancreatic fluid collection drainage: may not be business as usual?
    Gut. 2016 Nov 4. pii: gutjnl-2016-313187. doi: 10.1136/gutjnl-2016-313187.
    PubMed    


  139. HESSMANN E, Johnsen SA, Siveke JT, Ellenrieder V, et al
    Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?
    Gut. 2016 Nov 3. pii: gutjnl-2016-312539. doi: 10.1136/gutjnl-2016-312539.
    PubMed     Abstract available


    October 2016
  140. BAO Y, Prescott J, Yuan C, Zhang M, et al
    Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer.
    Gut. 2016 Oct 21. pii: gutjnl-2016-312510. doi: 10.1136/gutjnl-2016-312510.
    PubMed     Abstract available


  141. MACE TA, Shakya R, Pitarresi JR, Swanson B, et al
    IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.
    Gut. 2016 Oct 21. pii: gutjnl-2016-311585. doi: 10.1136/gutjnl-2016-311585.
    PubMed     Abstract available


  142. FAN X, Alekseyenko AV, Wu J, Peters BA, et al
    Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study.
    Gut. 2016 Oct 14. pii: gutjnl-2016-312580. doi: 10.1136/gutjnl-2016-312580.
    PubMed     Abstract available


  143. HART PA, Chari ST
    Preventing disease relapses in autoimmune pancreatitis with maintenance steroids: are we there yet?
    Gut. 2016 Oct 5. pii: gutjnl-2016-312738. doi: 10.1136/gutjnl-2016-312738.
    PubMed    


    September 2016
  144. WILLS ES, Drenth JP
    Building pancreatic organoids to aid drug development.
    Gut. 2016 Sep 21. pii: gutjnl-2016-312865. doi: 10.1136/gutjnl-2016-312865.
    PubMed    


  145. KONG B, Bruns P, Behler NA, Chang L, et al
    Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancy.
    Gut. 2016 Sep 19. pii: gutjnl-2015-310913. doi: 10.1136/gutjnl-2015-310913.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: